Logic controlled solid state switchgear

Logic controlled solid state circuit breakers and power transfer switches have been designed and built to demonstrate their use for 270 V dc power systems. This switchgear provides remote operation, automatic current level, and operates several orders of magnitude faster with much greater accuracy of response than conventional switchgear

The noise policy statement for England : significance, application and implications

The Noise Policy Statement for England, published by Defra in March 2010, describes a ‘policy vision to facilitate decisions regarding what is an acceptable noise burden to place on society’. The publication of the NPSE coincided with the formal adoption and publication of the Noise Action Plans as required by the Environmental Noise (England) Regulations 2006 (as amended) and the Environmental Noise Directive . However, the potential implications of the NPSE go much wider, and as this article shows, it may well turn out to have a considerable impact on the work of many members of the Institute of Acoustics

Influence of soil aeration on the growth of three grass species.

AgronomyDoctor of Philosophy (Ph.D.

Stopping relativistic Xe, Ho, Au and U nuclei in nuclear emulsions

Nuclei of Xe-54, Ho-67, Au-79 and U-92 accelerated at the Bevalac to energies between 1200 and 900 MeV/n were stopped in nuclear emulsions. The observed residual ranges were compared with those calculated from various models of energy loss and shown to be most consistent with a calculation that includes those higher order correction terms proposed previously to describe the energy loss of highly charged particles, for which the first Born approximation is not valid

Logic-controlled solid state switchgear for 270 volts dc

A feasibility study to design and demonstrate solid state switchgear in the form of circuit breakers and a power transfer switch is described. The switchgear operates on a nominal 270 V dc circuit and controls power to a load of up to 15 amperes. One circuit breaker may be interconnected to a second breaker to form a power transfer switch. On-off and transfer functions of the breakers or the transfer switch are remotely controlled. A number of reclosures with variable time delay between tripout and reclosure are programmed and controlled by integrated analog and COSMOS logic circuits. A unique commutation circuit, that generates only minimal transient disturbance to either source or load, was developed to interrupt current flow through the main SCR switching element. Laboratory tests demonstrated performance of the solid state circuit breakers over specified voltage and temperature ranges

NICMOS Imaging of the Dusty Microjansky Radio Source VLA J123642+621331 at z = 4.424

We present the discovery of a radio galaxy at a likely redshift of z = 4.424 in one of the flanking fields of the Hubble Deep Field. Radio observations with the VLA and MERLIN centered on the HDF yielded a complete sample of microjansky radio sources, of which about 20% have no optical counterpart to I < 25 mag. In this Letter, we address the possible nature of one of these sources, through deep HST NICMOS images in the F110W (J) and F160W (H) filters. VLA J123642+621331 has a single emission line at 6595-A, which we identify with Lyman-alpha at z = 4.424. We argue that this faint (H = 23.9 mag), compact (r = 0.2 arcsec), red (I - K = 2.0) object is most likely a dusty, star-forming galaxy with an embedded active nucleus.Comment: Accepted for publication in Astrophysical Journal Letters. 11 pages, 4 figures, uses aastex v5.0 and psfi

A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis

Transthyretin (TTR)-related amyloidosis (ATTR) is a devastating disease which affects a combination of organs including the heart and the peripheral nerves, and which has a fatal outcome if not treated within a average of 10 years. Tafamidis, or 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylic acid, selectively binds to TTR with negative cooperativity and kinetically stabilizes wild-type native TTR and mutant TTR; tafamidis therefore has the potential to halt the amyloidogenic cascade initiated by TTR tetramer dissociation, monomer misfolding, and aggregation. The first tafamidis trial, Fx-005, evaluated the effect of 18 months of tafamidis treatment (20 mg once daily) on disease progression, as well as assessing its safety in TTR-FAP Val30Met patients. The secondary objective of this trial was to study the pharmacodynamic stabilization of mutated TTR. Tafamidis proved effective in reducing the progress of neuropathy, and in maintaining the nutritional status and quality of life of stage 1 (able to walk without support) Val3OMet TTR-FAP patients. Furthermore, TTR stabilization was achieved in more than 90% of patients. An extension study, Fx-006, was conducted to determine the long-term safety and tolerability of tafamidis and to assess the efficacy of the drug on slowing disease progression. No significant safety or tolerability issues were noticed. Taken together, the results from both trials indicated that the beneficial effects of tafamidis were sustained over a 30-month period and that starting treatment early is desirable. Results are expected from an extended open-label study but data that have already been presented show that long-term use of tafamidis in Val30Met patients is associated with reduced progression in polyneuropathy. Tafamidis was initially approved for commercial use in Europe in 2011 and has since been approved for use in Japan, Mexico, and Argentina where it is used as a first-line treatment option for patients with early-stage TTR-FAP. Patients should be carefully followed at referral centers to ascertain the individual response to treatment. In cases of discontinuation, liver transplantation and enrollment in clinical trials of novel drugs aimed mostly toward suppression of TTR production are options